Skip to content

    Guardant Health (GH) stock price & financials

    View GH earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+154.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $191.48M
    $201.81M
    $203.47M
    $232.09M
    $265.20M
    +38.5%
    $281.27M
    +39.4%
    $301.67M
    +48.3%
    $334.98M
    +44.3%
    Strengthening
    Operating Profit
    -$117.33M
    -$125.97M
    -$111.04M
    -$106.41M
    -$98.99M
    +15.6%
    -$120.81M
    +4.1%
    -$121.35M
    -9.3%
    -$129.12M
    -21.3%
    Weakening
    Net Profit
    -$107.75M
    -$111.01M
    -$95.16M
    -$99.90M
    -$92.72M
    +13.9%
    -$128.49M
    -15.8%
    -$112.08M
    -17.8%
    -$120.14M
    -20.3%
    Weakening
    EPS
    $-0.88
    $-0.77
    $-0.80
    $-0.74
    +15.9%
    $-0.85
    -10.4%
    $-0.90
    -12.5%
    Weakening
    Other Income
    Interest
    $646.0K
    $645.0K
    $791.0K
    $983.0K
    $943.0K
    +46.0%
    $1.18M
    +82.9%
    $1.35M
    +70.3%
    $1.35M
    +36.9%
    Strengthening
    Depreciation
    Profit before Tax
    -$107.72M
    -$110.29M
    -$94.87M
    -$99.86M
    -$92.59M
    +14.0%
    -$130.22M
    -18.1%
    -$111.70M
    -17.7%
    -$119.96M
    -20.1%
    Weakening
    MarginsOPM
    -61.3%
    -62.4%
    -54.6%
    -45.9%
    -37.3%
    +39.1%
    -43.0%
    +31.2%
    -40.2%
    +26.3%
    -38.5%
    +15.9%
    Strengthening
    Tax
    -0.0%
    -0.7%
    -0.3%
    -0.0%
    -0.1%
    -400.0%
    1.3%
    -0.3%
    -6.5%
    -0.1%
    -275.0%
    Weakening
    ReturnsROIC
    3.3%
    3.4%
    2.9%
    3.1%
    2.9%
    -13.9%
    4.0%
    +15.8%
    3.5%
    +17.8%
    3.7%
    +20.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$140.54M$143.23M$832.98M$492.20M$141.65M$1.13B$525.54M$378.20M$1.05B
    Short-Term Investments$278.42M$379.57M$961.90M$440.55M$869.58M
    Total Current Assets$468.99M$597.36M$1.89B$1.11B$1.19B$1.35B$1.06B$1.47B$1.36B
    Net PP&E$31.00M$72.81M$100.13M$313.90M$341.92M$302.71M$279.08M$304.76M$302.87M
    Goodwill$0$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$77.26M$77.26M
    Intangibles$0$8.52M$16.16M$14.21M$11.73M$8.98M$6.76M$25.92M$25.27M
    Total Assets$587.40M$962.53M$2.27B$2.20B$1.61B$1.79B$1.49B$2.01B$1.91B
    LiabilitiesTotal Current Liabilities$46.94M$72.73M$66.81M$194.69M$193.22M$205.92M$225.58M$302.73M$338.96M
    Short-Term Debt
    Long-Term Debt$1.14B$1.50B$1.50B
    Long-Term Leases$33.26M$41.56M$226.05M$210.01M$185.85M$164.29M$178.46M$166.31M
    Total Liabilities$62.45M$114.54M$916.19M$1.56B$1.55B$1.63B$1.63B$2.11B$2.14B
    EquityCommon Stock & APIC
    Retained Earnings-$280.80M-$352.81M-$606.59M-$1.01B-$1.66B-$2.14B-$2.58B-$2.99B-$3.23B
    Total Equity$483.15M$798.39M$1.30B$645.00M$60.18M$158.68M-$139.65M-$99.31M-$222.87M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$72.19M-$47.13M-$103.93M-$209.02M-$309.46M-$324.98M-$239.86M-$184.76M-$185.19M
    Cash from Investing-$153.03M-$317.57M-$617.09M-$63.16M$149.82M$840.25M-$261.31M-$627.20M-$118.53M
    Cash from Financing$293.16M$367.30M$1.41B-$66.82M-$189.09M$477.38M-$996.0K$671.13M$737.80M
    SummaryCapital Expenditure-$20.20M-$18.72M-$36.17M-$75.03M-$77.46M-$20.49M-$35.09M-$48.31M-$55.54M
    Free Cash Flow-$92.39M-$65.85M-$140.10M-$284.05M-$386.92M-$345.46M-$274.94M-$233.07M-$240.72M
    FCF Margin-101.9%-30.7%-48.9%-76.0%-86.1%-61.3%-37.2%-23.7%-20.3%

    Ratios